S

Sarepta Therapeutics
D

SRPT

18.710
USD
0.26
(1.41%)
مغلق
حجم التداول
119,297
الربح لكل سهم
-1
العائد الربحي
-
P/E
-28
حجم السوق
1,958,411,941
أصول ذات صلة
AMGN
AMGN
3.67
(1.31%)
283.64 USD
BIIB
BIIB
0.690
(0.49%)
140.680 USD
BMRN
BMRN
1.140
(2.01%)
57.920 USD
GILD
GILD
2.270
(2.01%)
115.020 USD
INCY
INCY
1.220
(1.43%)
86.650 USD
I
IONS
1.905
(3.21%)
61.245 USD
R
RCKT
0.05000
(1.55%)
3.27500 USD
REGN
REGN
5.82
(1.03%)
572.98 USD
VRTX
VRTX
-0.65
(-0.16%)
396.16 USD
المزيد
الأخبار المقالات

العنوان: Sarepta Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.